X4 Pharmaceuticals XFOR
NASDAQ XFOR
$3.12 +0.11 (+3.65%)
As of: Oct 22, 2026 · 11:07 AM EDT

X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2017 - 2023)

Updated

X4 Pharmaceuticals (XFOR) reported Long-Term Debt Issuances of $20 million for FY2024, down 11.1% from $22.5 million in FY2023.

Analysis

X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2017 - 2023) Analysis & Trends

Dating back to FY2016, X4 Pharmaceuticals' Long-Term Debt Issuances record includes 7 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of 15.2% (FY2019 to FY2024).
  • The FY2024 figure ranks as the lowest annual Long-Term Debt Issuances since FY2020.
  • According to Business Quant data, Long-Term Debt Issuances came in at $22.5 million in FY2023 and $12.39 million in FY2020 (+25.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn -
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn -
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn -
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn -
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn -
10 X4 Pharmaceuticals 393.56 Mn -305.12 Mn 7.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 22.50 Mn
Dec 31, 2020 7.50 Mn
Mar 31, 2020 4.89 Mn
Jun 30, 2019 9.85 Mn
Dec 31, 2018 9.91 Mn
Dec 31, 2017 27.79 Mn
Sep 30, 2017 19,000.00
Jun 30, 2017 666,000.00
Mar 31, 2017 4.94 Mn
API Access

X4 Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=XFOR&period=max&api_key=YOUR_API_KEY